HealthEquity (NASDAQ: HQY) reported Q3 EPS of $0.60, $0.10 better than the analyst estimate of $0.50. Revenue for the quarter came in at $249.2 million versus the consensus estimate of $243.75 million.

GUIDANCE:

HealthEquity sees FY2024 revenue of $985-995 million, versus the consensus estimate of $989 million. Its outlook for net income is between $34 million and $39 million, resulting in net income of $0.39 to $0.45 per diluted share. Its outlook for non-GAAP net income, calculated using the method described below, is between $181 million and $188 million, resulting in non-GAAP net income per diluted share of $2.08 to $2.16 (based on an estimated 87 million diluted weighted-average shares outstanding). Management expects Adjusted EBITDA of $350 million to $360 million.

For the fiscal year ending January 31, 2025, management expects revenue of approximately $1.140 billion to $1.160 billion and Adjusted EBITDA of approximately 38-39% of revenue. These amounts assume an average annualized yield on HSA cash of approximately 3.00%.

For earnings history and earnings-related data on HealthEquity (HQY) click here.